United States · FDA National Drug Code directory

Female Liquescence

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 83027-0018_d4d33781-5365-4a0b-980d-9e3f2a825191
Product NDC: 83027-0018
Form: LIQUID
Composition / generic term: Dioscorea Villosa, Glycyrrhiza Glabra, Hamamelis Virginiana, Rubus Idaeus, Viburnum Opulus, Caulophyllum Thalictroides, Oophorinum (Suis), Uterus (Suis), Human Growth Hormone (HGH), Ignatia Amara
Labeler: Nutritional Specialties, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20230222 / 20280731

Source-listed ingredients

DIOSCOREA VILLOSA TUBER — 2 [hp_X]/mL
GLYCYRRHIZA GLABRA — 2 [hp_X]/mL
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK — 2 [hp_X]/mL
RUBUS IDAEUS LEAF — 2 [hp_X]/mL
VIBURNUM OPULUS BARK — 2 [hp_X]/mL
CAULOPHYLLUM THALICTROIDES ROOT — 3 [hp_X]/mL
SUS SCROFA OVARY — 6 [hp_X]/mL
SUS SCROFA UTERUS — 6 [hp_X]/mL
SOMATROPIN — 12 [hp_X]/mL
STRYCHNOS IGNATII SEED — 12 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

120 mL in 1 BOTTLE, GLASS (83027-0018-1) · 83027-0018-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →